Added to YB: 2017-10-25
Pitch date: 2017-10-25
RYTM:US [bullish]
Rhythm Pharmaceuticals, Inc.
+256.46%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Rhythm Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the rare neuroendocrine diseases.
Market Cap
$6.5B
Pitch Price
$28.94
Price Target
N/A
Dividend
N/A
EV/EBITDA
-34.58
P/E
-31.58
EV/Sales
36.65
Sector
Biotechnology
Category
N/A
Show full summary:
Rhythm Pharmaceuticals, Inc. RYTM:US
A summary for this pitch has not been created yet.
Read full article (0 min)